Health Condition 1: F028- Dementia in other diseases classified elsewhere
Conditions
Interventions
Intervention1: NEMA AI EEG–Cognitive Diagnostic Software (SaMD): The intervention involves the use of NEMA AI EEG–Cognitive Diagnostic Software, a non-invasive AI-driven platform that analyzes brainwa
Sponsors
NEMA AI AIIMS Delhi
NEMA AI
Eligibility
Inclusion criteria
Inclusion criteria: Cognitive deficits interfering with independence in everyday activities in case of major neurocognitive disorder or not interfering with independence in everyday activities in the case of minor neurocognitive disorder
Exclusion criteria
Exclusion criteria: Patients with other causes of neurocognitive impairment like metabolic, head injury, seizures, delirium etc. Patients with neurocognitive impairment due to psychiatric disorders like depression, schizophrenia etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the diagnostic accuracy of the NEMA AI EEG software in identifying patients with dementia as compared to the standard clinical and neuropsychological assessment methods. The analysis will focus on the software’s ability to accurately differentiate between dementia and non-dementia cases using brainwave-derived cognitive biomarkers.Timepoint: The outcome measures will be assessed at baseline pre-intervention, 4 weeks, and 8 weeks to examine the diagnostic consistency, reproducibility, and longitudinal stability of NEMA AI’s EEG-based analytical model across multiple patient evaluations. | — |
Secondary
| Measure | Time frame |
|---|---|
| To validate & publish a study with outcome of new model developed in the field of AI and health.Timepoint: 6 month study and publication timeline | — |
Countries
India
Contacts
Public ContactDr Divyani Garg
NEMA AI
Outcome results
None listed